TG Therapeutics | TGTX - Pre Tax Profit

Stock Price
28.86
Daily Change
1.10 3.96%
Monthly
-4.88%
Yearly
-12.78%
Q1 Forecast
27.97

TG Therapeutics reported $25.91M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 3.92B 2.35B Sep/2025
Ardelyx USD -867K 18.21M Sep/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Dynavax Technologies USD 28.42M 7.2M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
J&J USD 4.97B 2.53B Dec/2025
Novartis USD 4.2B 335M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
TG Therapeutics USD 25.91M 5.01M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025